nad has been researched along with Degenerative Diseases, Central Nervous System in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (17.46) | 29.6817 |
2010's | 26 (41.27) | 24.3611 |
2020's | 26 (41.27) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Lin, X; Liu, F; Pan, M; Sun, G; Tan, X; Zhao, K; Zhao, Q; Zheng, L | 1 |
Beura, S; Ghosh, R; Mishra, P; Modak, R | 1 |
Braidy, N; Helman, T | 1 |
Chen, X; Gao, M; Hu, C; Li, W; Zhou, Y | 1 |
Bommireddipalli, S; Bournazos, AM; Christodoulou, J; Cooper, ST; Garza, D; Gooley, S; Gunanayagam, K; Jones, DL; Linster, CL; Lunke, S; McLean, CA; Naidoo, P; Patraskaki, M; Rajasekaran, M; Sebire, D; Semcesen, LN; Sikora, T; Stroud, DA; Van Bergen, NJ; Wallis, M; Walvekar, AS; Warmoes, MO | 1 |
Duarte-Pereira, S; Matos, S; Oliveira, JL; Silva, RM | 1 |
Borén, J; Doganay, HL; Jin, H; Li, X; Mardinoglu, A; Nielsen, J; Ozturk, G; Turkez, H; Uhlén, M; Yang, H; Zhang, C | 1 |
Baur, JA; Bhasin, S; Migaud, M; Musi, N; Seals, D | 1 |
Lu, HC; Park, JH; Yang, S | 1 |
Green, M; Griffiths, JC; Ho, E; Huber, LG; Neufeld, LM; Obeid, R; Stout, M; Tzoulis, C | 1 |
Fang, EF; Lautrup, S; Mattson, MP; Sinclair, DA | 1 |
Fang, F; Gong, S; Li, J; Prokisch, H; Ren, X; Stenton, SL; Zhou, J | 1 |
Braidy, N; Liu, Y | 1 |
Castro-Portuguez, R; Sutphin, GL | 1 |
Bressac, L; Guerreiro, S; Privat, AL; Toulorge, D | 1 |
Chronister, WD; Fragola, G; Li, Z; Mabb, AM; Mao, H; McConnell, MJ; Niehaus, JK; Simon, JM; Taylor-Blake, B; Yuan, H; Zylka, MJ | 1 |
Christodoulou, J; Linster, CL; Van Bergen, NJ | 1 |
Abe, J; Borna, NN; Furukawa, T; Fushimi, T; Imai-Okazaki, A; Kishita, Y; Murayama, K; Ogawa-Tominaga, M; Ohtake, A; Okazaki, Y; Takeda, A | 1 |
Berger, NA; Kincaid, JW | 1 |
Jeong, H; Kim, KW; Lee, Y; Park, KH | 1 |
Musiek, ES; Smith, SK | 1 |
Gong, Z; Jiao, F | 1 |
Gao, W; Huang, C; Huber, PE; Li, C; Shen, G; Xie, N; Zhang, L; Zhou, X; Zou, B | 1 |
McCully, KS | 1 |
Kratz, EM; Kubis-Kubiak, A; Piwowar, A; Sołkiewicz, K | 1 |
Brazill, JM; Li, C; Zhai, RG; Zhu, Y | 1 |
Osborne, B; Samsudeen, AF; Sultani, G; Turner, N | 1 |
Hoek, JB; Rottenberg, H | 1 |
Nakagawa, T; Okabe, K; Yaku, K | 1 |
Ahting, U; Baple, E; Baptista, J; Becker-Kettern, J; Christodoulou, J; Conrotte, JF; Daubeney, P; Ellard, S; Ellaway, C; Girisha, KM; Guo, Y; Hakonarson, H; Homfray, T; Kay, DP; Kovacs-Nagy, R; Kremer, LS; Lewis, LES; Linster, CL; Massey, S; Montoya, J; Paczia, N; Power, R; Prelog, K; Pritsch, M; Procopis, P; Prokisch, H; Pyle, A; Rankin, J; Ruiz-Pesini, E; Santra, S; Shukla, A; Taylor, RW; Thorburn, DR; Van Bergen, NJ; Wakeling, M | 1 |
Klimova, N; Kristian, T | 1 |
Savitz, J | 1 |
Beal, MF; Lloret, A | 1 |
Hikosaka, K; Nakagawa, T; Okabe, K; Yaku, K | 1 |
Guarente, L; Herskovits, AZ | 1 |
Alleaume-Butaux, A; Brugg, B; Deleglise, B; Hjorth, JJ; Lassus, B; Peyrin, JM; Schneider, B; Soubeyre, V; Vignes, M; Viovy, JL | 1 |
Di Stefano, G; Manerba, M; Vettraino, M | 1 |
Sibon, OC; Srinivasan, B | 1 |
Gray, JJ; Linseman, DA; Stankiewicz, TR; Winter, AN | 1 |
Harrington, M | 1 |
Fishman, PS; Kristian, T; Long, AN; Owens, K; Schlappal, AE; Schuh, RA | 1 |
Auwerx, J; Cantó, C; Menzies, KJ | 1 |
Verdin, E | 1 |
Chang, B; Lu, S; Peng, J; Quan, Q; Wang, Y | 1 |
Scheibye-Knudsen, M | 1 |
Haigis, MC; Santos, D; van de Ven, RAH | 1 |
Fülöp, F; Klivényi, P; Toldi, J; Vámos, E; Vécsei, L; Zádori, D | 1 |
Aljada, A; Dong, L; Mousa, SA | 1 |
Balan, I; Kristian, T; Onken, M; Schuh, R | 1 |
Chertov, AO; Couron, D; Holzhausen, L; Hurley, JB; Kuok, IT; Linton, JD; Parker, E; Sadilek, M; Sweet, IR | 1 |
Braidy, N; Grant, R; Guillemin, GJ; Massudi, H | 1 |
Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC | 1 |
Giaume, C; Orellana, JA; Sáez, JC; von Bernhardi, R | 1 |
Bedalov, A; Simon, JA | 1 |
Buck, HM | 1 |
Adam-Vizi, V; Tretter, L | 1 |
Kennedy, BK; Longo, VD | 1 |
Belenky, P; Bogan, KL; Brenner, C | 1 |
Grant, RS; Jayasena, T; Keerthisinghe, N; Smythe, GA; Solaja, I | 1 |
Forouhar, F; Khan, JA; Tao, X; Tong, L | 1 |
Auwerx, J; Dali-Youcef, N; Froelich, S; Koehl, C; Lagouge, M; Schoonjans, K | 1 |
Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N | 1 |
Ying, W | 1 |
43 review(s) available for nad and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders.
Topics: Aging; Dietary Supplements; Humans; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide | 2023 |
NMNAT2: An important metabolic enzyme affecting the disease progression.
Topics: Axons; Disease Progression; Humans; NAD; Neurodegenerative Diseases; Nicotinamide-Nucleotide Adenylyltransferase; Wallerian Degeneration | 2023 |
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns.
Topics: Aged; Aging; Biology; Fatty Liver; Humans; NAD; Neurodegenerative Diseases | 2023 |
Axonal energy metabolism, and the effects in aging and neurodegenerative diseases.
Topics: Aging; Animals; Axons; Energy Metabolism; Glucose; Humans; NAD; Neurodegenerative Diseases | 2023 |
NAD
Topics: Aging; Animals; Brain; Cell Line; Humans; Mice; NAD; Neurodegenerative Diseases; Neurons; Rats | 2019 |
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
Topics: Aging; Animals; Humans; Inflammation; Mice; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide; Oxidative Stress; Pyridinium Compounds; Rats; Risk Assessment | 2020 |
Kynurenine pathway, NAD
Topics: Aging; Animals; Brain; Humans; Kynurenine; Longevity; Metabolic Networks and Pathways; Mice; Mitochondria; Mitophagy; NAD; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Tryptophan | 2020 |
CD38 in Neurodegeneration and Neuroinflammation.
Topics: ADP-ribosyl Cyclase 1; Aging; Animals; Astrocytes; Brain; Humans; Membrane Glycoproteins; Mice; Mice, Knockout; Microglia; NAD; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents | 2020 |
Effects of NAD
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; NAD; Nerve Regeneration; Neurodegenerative Diseases; Neuroprotection; Neurotoxins; Signal Transduction | 2020 |
Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases.
Topics: Chronobiology Disorders; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Sirtuins; Sleep Wake Disorders | 2020 |
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.
Topics: Animals; Brain Injuries, Traumatic; Humans; NAD; Neurodegenerative Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Sirtuin 1; Toll-Like Receptors | 2020 |
NAD
Topics: Aging; Cyclic ADP-Ribose; Humans; Metabolic Diseases; NAD; NADP; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction | 2020 |
Chemical Pathology of Homocysteine VIII. Effects of Tocotrienol, Geranylgeraniol, and Squalene on Thioretinaco Ozonide, Mitochondrial Permeability, and Oxidative Phosphorylation in Arteriosclerosis, Cancer, Neurodegeneration and Aging.
Topics: Aging; Animals; Arteriosclerosis; Cholesterol; Diterpenes; Homocysteine; Humans; Mitochondria; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Phosphorylation; Permeability; Squalene; Tocotrienols; Vitamin B 12 | 2020 |
Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators.
Topics: Gene Expression Regulation; Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; Sirtuins | 2021 |
NMNAT: It's an NAD
Topics: Amide Synthases; Humans; Molecular Chaperones; NAD; Neurodegenerative Diseases; Neurons; Nicotinamide-Nucleotide Adenylyltransferase | 2017 |
NAD
Topics: Aging; Animals; Homeostasis; Humans; NAD; Neoplasms; Neurodegenerative Diseases | 2017 |
The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.
Topics: Aging; Animals; Calcium; Caloric Restriction; Cyclophilins; Gene Expression Regulation; Humans; Ischemic Preconditioning; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; NAD; Neurodegenerative Diseases; Oxidation-Reduction; Reactive Oxygen Species; Reperfusion Injury | 2017 |
NAD metabolism: Implications in aging and longevity.
Topics: Aging; Animals; Humans; Longevity; NAD; Neoplasms; Neurodegenerative Diseases | 2018 |
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.
Topics: Animals; Brain; Humans; Hydrolases; Mitochondria; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide | 2019 |
The kynurenine pathway: a finger in every pie.
Topics: Aging; Animals; Energy Metabolism; Humans; Kynurenine; Mental Disorders; NAD; Neurodegenerative Diseases; Signal Transduction; Tryptophan | 2020 |
PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.
Topics: Animals; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Poly (ADP-Ribose) Polymerase-1; Sirtuins | 2019 |
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
Topics: Animals; Humans; Mitochondria; NAD; Neurodegenerative Diseases | 2021 |
Sirtuin deacetylases in neurodegenerative diseases of aging.
Topics: Aging; Caloric Restriction; Energy Metabolism; Histone Deacetylases; Humans; NAD; Neurodegenerative Diseases; Sirtuins | 2013 |
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.
Topics: Humans; Metabolic Diseases; NAD; Neoplasms; Neurodegenerative Diseases | 2013 |
Coenzyme A, more than 'just' a metabolic cofactor.
Topics: Animals; Coenzyme A; Humans; NAD; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor) | 2014 |
C-terminal binding proteins: central players in development and disease.
Topics: Alcohol Oxidoreductases; Animals; Apoptosis; Cell Survival; Co-Repressor Proteins; DNA-Binding Proteins; Growth and Development; Humans; NAD; Neoplasms; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Protein Conformation; Protein Processing, Post-Translational; Transcriptional Activation | 2014 |
NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.
Topics: Aging; Animals; Cell Nucleus; Energy Metabolism; Homeostasis; Humans; Metabolic Diseases; Mitochondria; Molecular Targeted Therapy; NAD; Neoplasms; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Sirtuins | 2015 |
NAD⁺ in aging, metabolism, and neurodegeneration.
Topics: Aging; Biosynthetic Pathways; Diabetes Mellitus, Type 2; DNA Damage; Fatty Liver; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Obesity; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Sirtuins | 2015 |
Molecular mechanisms in the initiation phase of Wallerian degeneration.
Topics: Animals; Axons; Humans; NAD; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Wallerian Degeneration | 2016 |
Neurodegeneration in accelerated aging.
Topics: Aging, Premature; Animals; Ataxia Telangiectasia; Bloom Syndrome; Cockayne Syndrome; DNA Repair; Dyskeratosis Congenita; Fanconi Anemia; Humans; Mitochondria; Mitophagy; NAD; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Progeria; Rothmund-Thomson Syndrome; Sirtuin 1; Telomere Shortening; Werner Syndrome; Xeroderma Pigmentosum | 2016 |
Mitochondrial Sirtuins and Molecular Mechanisms of Aging.
Topics: Aging; Animals; Hearing Loss; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Protein Interaction Maps; Sirtuins; Stress, Physiological | 2017 |
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.
Topics: Animals; Brain; Glutamic Acid; Humans; Kynurenic Acid; Mitochondrial Diseases; NAD; Neurodegenerative Diseases; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinolinic Acid; Tryptophan | 2009 |
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Topics: Alzheimer Disease; Drug Delivery Systems; Group III Histone Deacetylases; Histone Deacetylases; Humans; Longevity; Metabolic Diseases; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins | 2010 |
Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection.
Topics: ADP-ribosyl Cyclase 1; Animals; Cell Death; Humans; Metabolism; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; NAD; Neurodegenerative Diseases; Neuroprotective Agents | 2011 |
NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.
Topics: Aging; Animals; Cell Death; Cell Membrane; DNA Repair; Energy Metabolism; Enzyme Activation; Humans; Kynurenine; Mammals; NAD; Neurodegenerative Diseases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Sirtuins | 2012 |
Glial hemichannels and their involvement in aging and neurodegenerative diseases.
Topics: Adenosine Triphosphate; Aging; Astrocytes; Calcium; Cannabinoids; Central Nervous System; Connexin 43; Connexins; Dinoprostone; Glucose; Glutamic Acid; Humans; Inflammation; Interleukin-1beta; Ion Channels; NAD; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oligodendroglia; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.
Topics: Citric Acid Cycle; Humans; Ketoglutarate Dehydrogenase Complex; Mitochondria; NAD; Neurodegenerative Diseases; Oxidative Stress; Reactive Oxygen Species | 2005 |
Sirtuins in aging and age-related disease.
Topics: ADP Ribose Transferases; Aging; Animals; Diabetes Mellitus; Eukaryotic Cells; Histone Deacetylases; Humans; Models, Biological; NAD; Neoplasms; Neurodegenerative Diseases; Sirtuins | 2006 |
NAD+ metabolism in health and disease.
Topics: ADP Ribose Transferases; ADP-ribosyl Cyclase; Aging; Animals; Candida glabrata; Candidiasis; Humans; Lipids; NAD; Neurodegenerative Diseases; Niacinamide; Poly(ADP-ribose) Polymerases; Sirtuins | 2007 |
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.
Topics: Acrylamides; Adenosine Diphosphate Ribose; Aging; Animals; Antineoplastic Agents; Autoimmune Diseases; Clinical Trials, Phase II as Topic; Cyclic ADP-Ribose; DNA Damage; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Mice; NAD; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Piperidines; Poly Adenosine Diphosphate Ribose; Signal Transduction; Sirtuins; Tryptophan | 2007 |
Sirtuins: the 'magnificent seven', function, metabolism and longevity.
Topics: Animals; Caenorhabditis elegans; Caloric Restriction; Drosophila melanogaster; Energy Metabolism; Histone Deacetylases; Humans; Longevity; Mammals; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins | 2007 |
Tryptophan, adenosine, neurodegeneration and neuroprotection.
Topics: Adenosine; Animals; Hepatic Encephalopathy; Humans; Kynurenine; NAD; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Tryptophan | 2007 |
NAD+ and NADH in neuronal death.
Topics: Animals; Cell Death; Humans; NAD; Neurodegenerative Diseases; Neurons | 2007 |
1 trial(s) available for nad and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
The acute effect of different NAD
Topics: Humans; Metabolic Diseases; NAD; Neurodegenerative Diseases; Niacin; Niacinamide; Nicotinamide Mononucleotide | 2023 |
19 other study(ies) available for nad and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics.
Topics: Computational Biology; Extracellular Vesicles; Humans; NAD; Neurodegenerative Diseases; Oxidoreductases; Plant Roots; Polypodiaceae; Proteomics; Quinones | 2022 |
Nutritional Epigenetics: How Metabolism Epigenetically Controls Cellular Physiology, Gene Expression and Disease.
Topics: Chromatin; Epigenesis, Genetic; Gene Expression; Histones; Humans; Ketoglutaric Acids; NAD; Neurodegenerative Diseases | 2022 |
Severe NAD(P)HX Dehydratase (NAXD) Neurometabolic Syndrome May Present in Adulthood after Mild Head Trauma.
Topics: Adult; Brain Concussion; Brain Diseases, Metabolic; Child; Child, Preschool; Humans; Hydro-Lyases; Mitochondria; NAD; Neurodegenerative Diseases; Proteomics | 2023 |
Study of NAD-interacting proteins highlights the extent of NAD regulatory roles in the cell and its potential as a therapeutic target.
Topics: Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Signal Transduction | 2023 |
Advancing nutrition science to meet evolving global health needs.
Topics: Child; Choline; Chronic Disease; Dietary Supplements; Global Health; Humans; Infant; NAD; Neurodegenerative Diseases; Nutritional Sciences; Xanthophylls | 2023 |
NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
Topics: Humans; Hydro-Lyases; NAD; Neurodegenerative Diseases | 2020 |
Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration.
Topics: Animals; Apoptosis; Cerebral Cortex; DNA Damage; DNA Topoisomerases, Type I; Genomic Instability; Hippocampus; Inflammation; Mice; Mice, Knockout; Mortality, Premature; Motor Activity; Mutation; NAD; Neurodegenerative Diseases; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Pyridinium Compounds | 2020 |
Reply: NAD(P)HX dehydratase protein-truncating mutations are associated with neurodevelopmental disorder exacerbated by acute illness.
Topics: Acute Disease; Humans; Hydro-Lyases; Mutation; NAD; Neurodegenerative Diseases; Neurodevelopmental Disorders | 2020 |
NAD(P)HX dehydratase protein-truncating mutations are associated with neurodevelopmental disorder exacerbated by acute illness.
Topics: Acute Disease; Humans; Hydro-Lyases; Mutation; NAD; Neurodegenerative Diseases; Neurodevelopmental Disorders | 2020 |
NAD metabolism in aging and cancer.
Topics: Aging; Animals; Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Poly Adenosine Diphosphate Ribose | 2020 |
NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
Topics: Child, Preschool; Computer Simulation; Female; Fever; Fibroblasts; Genetic Vectors; Humans; Hydro-Lyases; Infant; Kinetics; Lentivirus; Male; Mitochondria; Mutation; NAD; Neurodegenerative Diseases; Primary Cell Culture; Whole Genome Sequencing | 2019 |
Synapto-protective drugs evaluation in reconstructed neuronal network.
Topics: Amides; Amino Acid Chloromethyl Ketones; Animals; Axons; Dendrites; Embryo, Mammalian; Enzyme Inhibitors; Mice; Microfluidics; Microscopy, Fluorescence; Models, Neurological; NAD; Nerve Net; Neurodegenerative Diseases; Primary Cell Culture; Pyridines; Resveratrol; Stilbenes; Synapses | 2013 |
Reversing neurodegenerative hearing loss.
Topics: Animals; Disease Models, Animal; Hearing Loss; Humans; Mice; Mice, Knockout; NAD; Neurodegenerative Diseases; Niacinamide; Pyridinium Compounds; Sirtuin 3 | 2015 |
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
Topics: Alzheimer Disease; Animals; Brain; Female; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Nicotinamide Mononucleotide; Oxygen Consumption | 2015 |
Roles of glucose in photoreceptor survival.
Topics: Acetylglucosamine; Adenosine Triphosphate; Animals; Autophagy; Cell Death; Cell Survival; Gas Chromatography-Mass Spectrometry; Glucose; Lactic Acid; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Oxygen Consumption; Photoreceptor Cells, Vertebrate; Retina | 2011 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2012 |
Neuroscience. NAD to the rescue.
Topics: Animals; Axons; Cell Nucleus; Cell Survival; Cells, Cultured; Ganglia, Spinal; Mice; Mutation; NAD; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Nicotinamide-Nucleotide Adenylyltransferase; RNA, Small Interfering; Sirtuin 1; Sirtuins; Ubiquitin-Protein Ligases; Wallerian Degeneration | 2004 |
The role of the carboxamide group in nicotinamide adenine dinucleotide in relation to hydride transfer: the reduced form of the dinucleotide as remedy in the modulation of neurotransmission.
Topics: Adenine Nucleotides; Amides; Animals; Carbon; Dinucleoside Phosphates; Humans; Hydrogen; Kinetics; Molecular Conformation; NAD; Neurodegenerative Diseases; Neurons; Nitrogen; Nucleotides; Protein Folding; Stereoisomerism; Synaptic Transmission | 2005 |
Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
Topics: Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Cytoplasm; Humans; Hydroxyl Radical; Intracellular Fluid; Iron Chelating Agents; Membrane Lipids; NAD; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress | 2007 |